{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:35:57Z","timestamp":1786718157174,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_990_15","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:20:40Z","timestamp":1505280040000},"page":"789","source":"Crossref","is-referenced-by-count":9,"title":["Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma"],"prefix":"10.4103","volume":"14","author":[{"given":"Xiangping","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.214520-1","first-page":"892","volume-title":"Surveillance scanning of children with medulloblastoma","author":"Torres","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.214520-2","first-page":"671","volume-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","author":"Gerber","year":"2005","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.214520-3","first-page":"427","volume-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.214520-4","first-page":"119","volume-title":"Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: A preliminary report","author":"Yomo","year":"2016","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0973-1482.214520-5","first-page":"369","volume-title":"A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema","author":"Wang","year":"2014","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0973-1482.214520-6","first-page":"129","volume-title":"Research progress on the mechanisms of combined bevacizumab and radiotherapy","author":"Zhuang","year":"2014","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"key-10.4103\/0973-1482.214520-7","first-page":"384","volume-title":"Functional VEGF and VEGF receptors are expressed in human medulloblastomas","author":"Slongo","year":"2007","journal-title":"Neuro Oncol"},{"key":"key-10.4103\/0973-1482.214520-8","first-page":"589","volume-title":"Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: A multi-institutional experience","author":"Aguilera","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"key-10.4103\/0973-1482.214520-9","first-page":"1073","volume-title":"Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent\/refractory solid tumors","author":"Okada","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key-10.4103\/0973-1482.214520-10","first-page":"e68416","volume-title":"A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors","author":"Venkatramani","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214520-11","first-page":"1939","volume-title":"Pediatric patients with refractory central nervous system tumors: Experiences of a clinical trial combining bevacizumab and temsirolimus","author":"Piha-Paul","year":"2014","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0973-1482.214520-12","first-page":"511","volume-title":"Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors","author":"Peyrl","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/0973-1482.214520-13","first-page":"106","volume-title":"Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma","author":"Korah","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0973-1482.214520-14","first-page":"245385","volume-title":"Metastatic medulloblastoma in childhood: Chang's classification revisited","author":"Dufour","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"key-10.4103\/0973-1482.214520-15","first-page":"5","volume-title":"Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma","author":"Bowers","year":"2007","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0973-1482.214520-16","first-page":"232","volume-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0973-1482.214520-17","first-page":"220","volume-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"key-10.4103\/0973-1482.214520-18","first-page":"218","volume-title":"Bevacizumab plus chemotherapy versus chemotherapy alone for preventing brain metastasis derived from advanced lung cancer","author":"Fu","year":"2016","journal-title":"J Chemother"},{"key":"key-10.4103\/0973-1482.214520-19","first-page":"5","volume-title":"Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis","author":"Pishko","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"key-10.4103\/0973-1482.214520-20","first-page":"555","volume-title":"Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells","author":"Davare","year":"2014","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:31:50Z","timestamp":1786714310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_990_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"alternative-id":["214520"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_990_15","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}